Figure S1: Overview of PMTCT Options A and B. Prevention of Mother to Child HIV Transmission (PMTCT)
|
|
- Clarence Jacobs
- 6 years ago
- Views:
Transcription
1 Figure S1: Overview of PMTCT Options A and B Prevention of Mother to Child HIV Transmission (PMTCT) Option A: combined Antiretroviral therapy (ART) for all women meeting WHO 2010 criteria for initiation (CD4<350, WHO Stage III or IV) and Nevirapine for the infant during the first 6 weeks of breast-feeding. For those women with CD4>350 or WHO Stage I/II, prophylactic (short course) treatment with Zidovudine for the mother during pregnancy from the 14 th week of gestation; intra-partum combined ART, and Nevirapine for the infant during the entire breast-feeding period 21. Option B: Combined ART for all women regardless of CD4 and clinical stage. However, this is stopped after complete cessation of breastfeeding in those women not meeting WHO 2010 criteria for ART initiation (CD4>350 or WHO Stage I or II). Nevirapine is given to the infant during the first 6 weeks of the breast-feeding period 21.
2 Supplementary information S1: Details of PMTCT B+ pilot implementation in Nhlangano Health Zone, Shiselweni, Swaziland (Jan July 2013) Clinical SOPs for the PMTCT B+ pilot programme were developed by MSF with support from the Swaziland National AIDS Program (SNAP) and the Sexual and Reproductive Health Unit (SRHU) of the Ministry of Health. When the pilot was launched, the country as a whole continued to follow the PMTCT option A approach. Sensitisation of the population of Nhlangano health zone, selected for the PMTCT B+ pilot, relied on stakeholder meetings, training workshops for health workers, and community mobilisation carried out within the health zone, rather than media (TV, radio or print). Combined ART would henceforth be offered to all pregnant and breastfeeding HIV+ women after counselling. Ideally it should be initiated within one week of the first ANC appointment, and no later than 32 weeks gestation. After discussion with the SRHU, it was agreed that prophylactic therapy (Zidovudine for mother, Nevirapine for baby) would still be offered to women refusing combined ART, since if this was not offered women hesitant about starting ART might seek care in other health zones, or may leave the ANC visit without an effective ARV intervention for preventing vertical transmission. At the start of the pilot study, same day initiation of combined ART was not encouraged. This decision was made following discussions with the National PMTCT Technical Working Group (led by the Swaziland Ministry of Health), where it was felt that same-day initiation would result in coercion of patients and high early attrition. However, after 3 months it was noted that median time to ART initiation was well over the one-week target, a decision was made to adapt the SOPs in favour of same-day initiation, for women who were ready. Women not ready to initiate would be invited for review one week later, at which time prophylactic therapy (Zidovidine/ Nevirapine) would be proposed if the woman was still not ready to start combined ART. These updated SOPs were issued in July 2013 and are available online (online supplementary information S2).
3 PMTCT B+ - Standard Procedures for Antenatal care All pregnant women should have an HIV test (unless known to be HIV+), and be screened for TB. If TB suspect, follow up care as usual. Encourage partner to be tested for HIV, and invite him to next visit. If the patient tests negative for HIV: Provide HIV post test counselling, including condom demonstration and strategies for risk reduction. Ensure partner knows his HIV status. Advise the patient that they should be retested for HIV every 8 weeks throughout pregnancy and breast-feeding If the patient is known to be HIV+, and is already on combined ART: Continue her current treatment. This includes TDF and EFV based regimens, which are safe in pregnancy. Ensure patient has a Chronic Care file, and is registered in the ART register If the patient is HIV+ but not on combined ART (i.e. newly diagnose, or previously diagnosed but not on treatment, or only taking AZT prophylaxis): Ensure post-test counselling if newly diagnosed HIV+. Open file and register in the pre-art register. Carry out clinical staging and ensure standard lab tests are done: Hb, CD4 (if not done in last 3 months), VL, renal function, liver function, Urinalysis. If available, do VDRL, Hep B and C. Explain that in Nhlangano zone, all HIV+ pregnant women are recommended cart. Ensure that she has seen the PMTCT information sheet available in the clinic. Initiate cart if no contraindications, and ensure patient is registered in the ART register. o Refer to EC for 1 st session of ART readiness counselling today. EC should book 2 nd session for within 1 week. Her 3 rd counselling session should happen at her next ANC visit. If the woman is not ready to initiate ART today, do not give AZT (unless > 32 weeks pregnant)*. Book a 2 nd appointment for 1 week, and refer to EC for 1 st session ART readiness counselling today o At the 2 nd appointment, initiate cart if no contraindications and she is now ready. Refer to EC for 2 nd session of ART readiness counselling today (3 nd session at next ANC appointment) o If the woman is still not ready to start ART, address her concerns and remind her of the need for ART to protect the baby. If she still refuses ART, start the prophylactic regimen (AZT for mother from 14 weeks of pregnancy, intra-partum ARVs, extended NVP for baby). o If the woman misses any appointment, call her and book an urgent appointment. When she next comes to ANC, initiate cart if no contraindications and she is now ready. If the woman is still not ready to start ART, start the prophylactic (AZT-based) regimen. All pregnant women should receive NVP syrup for the baby At every visit, give adherence counselling (Nurse and EC) for all patients newly initiated on cart. * If the woman is more than 32 weeks pregnant, she must not leave the clinic without an ARV treatment (initiate cart if she is ready, if not the prophylactic (AZT-based) regimen).
4 PMTCT B+ - Standard Procedures for Antenatal care Known HIV+ on ART Known HIV+ not on cart (includes women on AZT). Check Hb, U&E, LFT, urine, Staging, CD4, VL. HIV- or unknown Do HIV test HIV + Do post-test counseling; enroll in pre- ART. Check Hb, U&E, LFT, urine, Staging, CD4, VL. HIV - give post-test counseling Continue current ART regimen. Explain that she should start cart today. If she is already on AZT, offer to change Re-test for HIV at every visit. If not ready to start ART do not give AZT* Refer to EC for 1 st ART readiness counseling Book 2 nd appointment within 1 week. If patient does not attend counseling visit, contact patient and book to see nurse. At 2 nd appointment, counsel patient on ART Initiate ART (TDF-3TC-EFV) ᶧ Enroll in ART register. Give 1 bottle NVP for baby Refer to EC for ART readiness counseling today continue to complete 3 counselling sessions (before or after initiation) Give ongoing adherence support Patient to see Nurse and EC at every visit Phone patient if she misses any appointment Patient now ready to initiate ART Patient still not ready to initiate ART at 2 nd appt: Offer prophylactic treatment with AZT Give 1 bottle NVP syrup for baby. Offer patient the option to change to ART at every visit Note: * If the woman is more than 32 weeks pregnant, she must not leave the clinic without an ARV treatment (initiate cart if she is ready, if not the prophylactic (AZT-based) regimen). ᶧ Contraindications to TDF-3TC-EFV are summarized in the National ART Guidelines. If the woman has renal impairment, AZT-3TC-EFV can be given. If EFV intolerant, use NVP based regimens
5 PMTCT B+ - Standard Procedures for Maternity care All pregnant women should have an HIV test (unless known to be HIV+), and be screened for TB. If TB suspect, follow up care as usual. Encourage partner to be tested for HIV, and invite him to next visit. If the patient tests negative for HIV: Provide HIV post test counselling, including condom demonstration and strategies for risk reduction. Ensure partner knows his HIV status. Advise the patient that they should be retested for HIV every 8 weeks throughout breast-feeding If the patient is known to be HIV+, and is already on combined ART: Continue her current treatment If the patient is HIV+ but not on combined ART (i.e. newly diagnosed, or previously diagnosed but not on treatment, or only taking AZT prophylaxis): Provide post-test counselling in the case of a new diagnosis of HIV. Ensure the patient has a Chronic Care file, and is registered in the pre-art register Ensure that the patient has seen the PMTCT information sheet available in the facility. Explain that in Nhlangano Zone, all HIV+ pregnant and breast-feeding women are now recommended combined ART. Address any questions she has about this. Inform the woman that she will be offered this treatment at the PHU / Clinics after her discharge. To protect the baby, the woman should receive single dose intra-partum Nevirapine and 1 week AZT / 3TC. She should also receive 1 bottle of Nevirapine syrup for the baby. However, at discharge from maternity, the woman is referred to the PHU or PHC for initiation of combined ART. If the woman is discharged when the PHU is closed, she should be advised to attend the PHU or PHC as soon as possible. Give appointment date at the mother s PHC or PHU, and document in the mother s card and child welfare card. Document mother s contact details, and the details of her treatment supporter (e.g. cell phone numbers) both in the mothers file and the maternity and appointment register.
6 PMTCT B+ - Standard Procedures for Maternity care HIV + on combined ART HIV + on AZT or no PMTCT treatment HIV or unknown Do HIV test Normal maternity care. HIV + do post-test counseling and enroll in pre-art care HIV- give posttest counseling. Continue normal maternity care Explain that she should initiate ART after delivery (if on AZT, can change to combined ART) At delivery, give SD NVP and AZT/3TC for 7 days to mother, initiate NVP syrup for baby Refer to PHU or PHC after delivery for initiation of combined ART Note: The algorithm is applicable only in early labour or after delivery. If woman presents in advanced labour, the algorithm should be applied after delivery, before the mother is discharged from maternity.
7 PMTCT B+ - Standard Procedures for Postnatal and Child Welfare follow-up All women should have an HIV test (unless known to be HIV+), and be screened for TB. If TB suspect, follow up care as usual. Encourage partner to be tested for HIV, and invite him to next visit. If the patient tests negative for HIV: Provide HIV post test counselling, including condom demonstration and strategies for risk reduction. Ensure partner knows his HIV status. Advise the patient that they should be retested for HIV every 8 weeks throughout breast-feeding. If the patient is known to be HIV+, and is already on combined ART: Continue her current treatment. Check her Viral Load if not done at delivery. The mother s viral load should be rechecked every 6 months until baby is 2 years old. If the patient is HIV+ but not on combined ART (i.e. newly diagnosed, or previously diagnosed but not on treatment, or only taking AZT prophylaxis during pregnancy): Give post-test counselling if newly diagnosed HIV+. Open file and register in the pre-art register. Explain that in Nhlangano zone, all HIV+ pregnant women are recommended cart. Ensure that she has seen the PMTCT information sheet available in the clinic. Start Nevirapine syrup for the baby (if breast-feeding). Explain that all HIV+ breast-feeding women are recommended combined ART. Ensure that she has seen the PMTCT information sheet. Carry out standard lab tests if not done since delivery: Hb, CD4 (if not in last 3 months), VL, renal / liver function, urinalysis. If available: VDRL, Hep B and C. Check baby s HIV status if due (see algorithm). If baby s DNA PCR test is positive, the baby must also be initiated on ART immediately. Start mother on cart if no contraindications, and ensure patient is registered in the ART register. o Refer to EC for 1 st session of ART readiness counselling today. EC should book 2 nd session for within 1 week. Her 3 rd counselling session should happen at the next PNC / CW visit. If the woman is not ready to initiate ART today, book a 2 nd appointment for 1 week, and refer to EC for 1 st session of ART readiness counselling today o At the 2 nd appointment, initiate cart if no contraindications and she is now ready. Refer to EC for 2 nd session of ART readiness counselling today (3 nd session at next routine visit) o If the woman is still not ready to start ART, remind her of the need for ART to protect the baby. If she still refuses ART, continue extended Nevirapine for whole breastfeeding period. o If the woman misses any appointment, call her and book an urgent appointment. When she next comes to ANC, initiate cart if no contraindications and she is now ready. If the woman is still not ready to start ART, continue Nevirapine for the whole breasteeding period At every visit, give adherence counselling (Nurse and EC) for all patients newly initiated on cart. The mother s viral load should be rechecked every 6 months until baby is 2 years old.
8 PMTCT B+ - Standard Procedures for Postnatal and Child Welfare follow-up HIV + on combined ART HIV + mother not on ART, baby receiving NVP or nothing. Check Hb, U&E, LFT, urine, Staging, CD4, VL. HIV- or unknown do HIV test Do VL test at first post-natal visit HIV + do post-test counseling and enroll in pre-art care. Check Hb, U&E, LFT, urine, HIV- give post-test counseling. Repeat HIV test every 8 weeks during breastfeeding. Explain that she should start cart today. Start NVP syrup for baby Check HIV status of baby if due, and change baby to cart if positive Initiate ART (TDF-3TC-EFV) Enroll in ART register. Complete 6 weeks NVP syrup for baby (but change baby to cart if baby tests HIV+). Refer to EC for ART readiness counseling today continue to complete 3 counselling sessions (before or after initiation) Mother not ready to start ART today. Refer to EC for 1 st ART readiness counseling Book 2 nd appointment within 1 week. If patient does not attend counseling session, contact patient and book to see nurse. At 2 nd appointment, counsel patient on ART Mother now ready to initiate cart Give ongoing adherence support Counsel mother on importance of HIV test for infant at 12 and 18 months. Check mothers VL at 6, 12 and 18 month visits*. Mother not ready to initiate ART at 2 nd appt Continue NVP syrup for baby for breastfeeding period (but change baby to cart if baby is HIV+) Note: * Women in the PMTCT program should have a VL test at enrolment, at delivery and every 6 m thereafter. Any patient with detectable viral load after > 6 months on ART should be referred for stepped-up adherence counseling, according to the viral load monitoring algorithm. ᶧ Contraindications to TDF-3TC-EFV are summarized in the National ART Guidelines. If the woman has renal impairment, AZT-3TC-EFV can be given. If EFV intolerant, use NVP based regimens
9 HIV Exposed Infant Age 6 Weeks to 12 Months Perform DNA PCR test Give cotrimoxazole. NVP prophylaxis if BF and mom not on ART*. Encourage EBF for 6 mos, then BF plus complementary foods until at least 12 mos and safe to stop BF. For mother: check CD4 and offer family planning. DNA PCR POSITIVE Sick Child? Repeat DNA PCR if initial test was negative. Refer to doctor at any time if clinical suspicion of HIV. DNA PCR NEGATIVE Breastfed in the 6 weeks before testing? Child is HIV POSITIVE Refer to ARV clinic Continue cotrimoxazole Stop NVP prophylaxis Continue BF as long as possible For mother: check CD4 offer family planning Repeat DNA PCR or check viral load when baseline labs drawn YES Child is STILL EXPOSED Continue cotrimoxazole NVP prophylaxis if BF and mom not on ART* Encourage EBF for 6 mos, then BF plus complementary foods until at least 12 mos and safe to stop BF For mother: check CD4 and offer family planning Repeat HIV testing 6 weeks after cessation of BF NO Child is HIV NEGATIVE Stop cotrimoxazole Stop NVP prophylaxis* For mother: check CD4 and offer family planning Repeat Rapid Test at 18 months for confirmation *NVP prophylaxis should be stopped 1 week after BF cessation
10 HIV Exposed Child Age 12 to 18 Months Perform Rapid Test A Rapid test A POSITIVE Perform DNA PCR test Check CD4; Refer to ARV clinic Cont BF and reassess when DNA PCR result returns. Give cotrimoxazole. Cont NVP prophylaxis if BF and mom not on ART*. DNA PCR POSITIVE DNA PCR NEGATIVE Sick Child? Repeat Rapid Test and DNA PCR if initial test was negative. Refer to doctor at any time if clinical suspicion of HIV. Rapid Test A NEGATIVE Breastfed in the 2 months before testing? Breastfed in the 6 weeks before testing? YES NO YES NO Child is HIV POSITIVE Refer to ARV clinic Continue cotrimoxazole. Stop NVP prophylaxis. Continue BF as long as possible For mother: Check CD4 and. offer family planning Repeat DNA PCR or check viral load when baseline labs drawn Child is STILL EXPOSED Continue cotrimoxazole NVP prophylaxis if BF and mom not on ART*. Encourage BF and complementary foods until safe to stop BF. For mother: Check CD4 a offer FP family planning Repeat Rapid Test 2 months after cessation of BF Child is HIV NEGATIVE Stop cotrimoxazole. Stop NVP prophylaxis*. For mother: Check CD4 offer family planning. Repeat Rapid Test at 18 months for confirmation While awaiting DNA PCR results, immediate referral to ARV clinic is recommended due to a high likelihood of true infection. * NVP prophylaxis should be stopped 1 week after BF cessation
11 HIV Exposed Child Age 18 Months or Older Perform Rapid Test A Rapid Test A POSITIVE Perform Rapid Test B Sick Child? Repeat Rapid Test if initial test was negative. Refer to doctor at any time if clinical suspicion of HIV. Rapid Test B NEGATIVE Breastfed in the 2 months before testing? Rapid Test B POSITIVE Rapid Test B NEGATIVE YES NO INCONCLUSIVE Result Continue cotrimoxazole. Continue NVP prophylaxis if BF and mom not on ART*. Send blood sample to national lab as tie breaker For Mother: Check CD4 and offer for family planning. Child is HIV POSITIVE Refer to ARV clinic. Continue cotrimoxazole. Stop NVP. Continue BF as long as possible For Mother: Check CD4 and i offer for family planning. Child is STILL EXPOSED Continue cotrimoxazole. Continue NVP prophylaxis if BF and mom not on ART*. Encourage BF and complementary foods until safe to stop BF. For Mother: Check CD4 and i offer family planning. Repeat Rapid Testing 2 months after cessation of BF Child is HIV NEGATIVE Stop cotrimoxazole. Stop NVP prophylaxis*. For Mother: Check CD4 and offer for family planning. * NVP prophylaxis should be stopped 1 week after BF cessation
TOWARDS ELIMINATION OF MOTHER TO CHILD TRANSMISSION OF HIV
TOWARDS ELIMINATION OF MOTHER TO CHILD TRANSMISSION OF HIV Gladwel Muthoni KPA Conference 24 th April, 2018 OUTLINE Burden of HIV in PMTCT Mechanism and timing of Mother to Child Transmission (MTCT) Four
More informationThe New National Guidelines. Feeding in the Context of HIV. Dr. Godfrey Esiru; National PMTCT Coordinator
The New National Guidelines (2010) for PMTCT and Infant Feeding in the Context of HIV Dr. Godfrey Esiru; National PMTCT Coordinator Presentation outline Evolution of the PMTCT guidelines in Uganda Rational
More informationTHE SOUTH AFRICAN ANTIRETROVIRAL TREATMENT GUIDELINES 2010
THE SOUTH AFRICAN ANTIRETROVIRAL TREATMENT GUIDELINES 2010 The South African Antiretroviral Treatment Guidelines 2010 Goals of the programme Achieve best health outcomes in the most cost-efficient manner
More informationUPDATE TRAINING ARV TREATMENT GUIDELINES TRAINERS CASE STUDIES & ANSWER GUIDE
UPDATE TRAINING ARV TREATMENT GUIDELINES TRAINERS CASE STUDIES & ANSWER GUIDE 3/13/2013 Contents Group Work Instructions... 2 PMTCT... 3 Case Study 1: Unbooked Pregnant Women... 3 Case Study 2: First ANC
More informationUpdates on Revised Antiretroviral Treatment Guidelines Overview 27 March 2013
Updates on Revised Antiretroviral Treatment Guidelines 2013 Overview 27 March 2013 Introduction of Fixed Dose combination (FDC) FDCs will be available in facilities on 1 April 2013 The FDC ARV that will
More informationOutline. Aim with PMTCT. How are children transmitted. Prevention of mother-to-child transmission of HIV. How does HIV transmit to children?
Prevention of mother-to-child transmission of HIV Outline AimofPMTCT How HIV is transmitted to children Epidemiology of HIV in children How to reduce HIV transmission to children Guidelines Lars T. Fadnes
More informationApplying Improvement to Keep HIV+ Mothers and Exposed Infants in Care. Anisa Ismail Improvement Advisor University Research Co.
Applying Improvement to Keep HIV+ Mothers and Exposed Infants in Care Anisa Ismail Improvement Advisor University Research Co., LLC 1 What if you found out you were pregnant? What if you knew you were
More informationObjectives. Types of HIV Tests. Age Appropriateness of Tests. Breastfeeding and HIV Testing. Why are there different tests for different ages?
Objectives At the end of the lesson participants will be able to: Identify the types of HIV tests available in Botswana State who should be tested Identify which tests are used for infants and children
More informationDEPARTMENT. Treatment Recommendations for. Pregnant and Breastfeeding Women: Critical Issues Consolidated ARV Guidelines. Dr.
2013 Consolidated ARV Guidelines H I V / A I D S Treatment Recommendations for DEPARTMENT Pregnant and Breastfeeding Women: Critical Issues Dr. Nathan Shaffer Objectives of Presentation obackground ooverview
More informationhiv/aids Programme Use of Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants
hiv/aids Programme Programmatic update Use of Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants EXECUTIVE SUMMARY April 2012 EXECUTIVE SUMMARY Recent developments
More informationPAEDIATRIC HIV INFECTION. Dr Ashendri Pillay Paediatric Infectious Diseases Specialist
PAEDIATRIC HIV INFECTION Dr Ashendri Pillay Paediatric Infectious Diseases Specialist Paediatric HIV Infection Epidemiology Immuno-pathogenesis Antiretroviral therapy Transmission Diagnostics Clinical
More informationUpdate on global guidelines. and emerging issues on perinatal HIV prevention. WHO 2013 Consolidated ARV Guidelines
WHO 2013 Consolidated ARV Guidelines Update on global guidelines H I V / A I D S DEPARTMENT and emerging issues on perinatal HIV prevention Children & HIV, St. Petersburg, Russia Sept 25-26, 2014 Dr. Nathan
More informationPeter Elyanu 1, Addy Kekitiinwa 2,Rousha Li 1, Mary Paul 3, LY Hwang 1
OUTCOMES OF HIV EXPOSED INFANTS BEFORE AND AFTER IMPLEMENTING OPTION B+ PMTCT GUIDELINE IN KAMPALA,UGANDA: A RETROSPECTIVE COHORT STUDY. Peter Elyanu 1, Addy Kekitiinwa 2,Rousha Li 1, Mary Paul 3, LY Hwang
More informationXVII INTERNATIONAL AIDS CONFERENCE MEXICO CITY, 3-8 August 2008 SCALING-UP NATIONAL PMTCT PROGRAM
XVII INTERNATIONAL AIDS CONFERENCE MEXICO CITY, 3-8 August 2008 SCALING-UP NATIONAL PMTCT PROGRAM Phasing more efficacious ARV regimen for PMTCT in resource limited setting Lessons Learned from RWANDA
More informationtreatment during pregnancy and breastfeeding
treatment during pregnancy and breastfeeding Topics covered Introduction. Preventing parent-to-child transmission. AZT as a single therapy. Treatment begun late in pregnancy. Nevirapine for mothers and
More informationScholars Research Library. Changing trends of HIV infection in children with relation to the ongoing PPTCT programme
Journal of Microbiology and Biotechnology Research Scholars Research Library (http://scholarsresearchlibrary.com/archive.html) ISSN : 2231 3168 CODEN (USA) : JMBRB4 Changing trends of HIV infection in
More informationPregnancies amongst adolescents and young women 16% of all births - 19% will have repeat pregnancies before age 20
Introduction Pregnancies amongst adolescents and young women 16% of all births - 19% will have repeat pregnancies before age 20 Proportions HIV infections 19% amongst adolescents (- 29.5% nationally 15
More informationWales Neonatal Network Guideline CARE OF THE BABY WHO HAS BEEN BORN TO AN HIV POSITIVE MOTHER
CARE OF THE BABY WHO HAS BEEN BORN TO AN HIV POSITIVE MOTHER A plan of care is written for all babies to be born to a woman with HIV infection. These are placed in the maternal notes within the Baby Pack
More informationESSENTIAL PACKAGE FOR HIV CARE AND TREATMENT. Essential Package for HIV Care and Treatment
ESSENTIAL PACKAGE FOR HIV CARE AND TREATMENT Essential Care & Treatment Package for Adult PLHIV 1. All patients should have a confirmed and documented HIV diagnosis in their file 2. All HIV infected adults
More informationRevised Anti- Retroviral Treatment Guideline Update For Frontline Clinical Health Professionals 3/13/2013
Revised Anti- Retroviral Treatment Guideline Update For Frontline Clinical Health Professionals 3/13/2013 The following document highlights the changes National department of Health ARV treatment guidelines
More informationThe Global Fund s role as a strategic and responsible investor in HIV/AIDS: Paediatrics and PMTCT
The Global Fund s role as a strategic and responsible investor in HIV/AIDS: Paediatrics and PMTCT Peter McDermott Managing Director, CIFF 19 th Board meeting, Geneva 6 th May 2009 Investment Criteria Measurable...change
More informationMonitoring of HIV positive mothers and HIV exposed infants in context of Option B+ implementation
Monitoring of HIV positive mothers and HIV exposed infants in context of Option B+ implementation Kenya Outline of the presentation Background: Kenya in Context PMTCT Program progress 2012-2015 Option
More informationThe 2017 Namibia ART Guidelines. Tadesse T. Mekonen, MD, MPH, AAF-HIV
The 2017 Namibia ART Guidelines Tadesse T. Mekonen, MD, MPH, AAF-HIV Q1-Table 1 List at least four key new recommendations in the 2017 Namibian ART Guidelines Q2-Table-2 46yo, Male, on AZT/TDF/FTC/ATVr
More informationLiving Positively with HIV
Living Positively with HIV Pregnancy and Planning a Family How do I avoid pregnancy and STI? What is this booklet for? This booklet gives basic information about planning a family if you are living with
More informationCUMULATIVE PERINATAL HIV EXPOSURE, AUSTRALIA. Date
CUMULATIVE PERINATAL HIV EXPOSURE, AUSTRALIA 350 300 250 Number 200 150 100 50 0 1/01/1997 1/01/1998 1/01/1999 1/01/2000 31/12/2000 31/12/2001 31/12/2002 Date July 2004 Reported number of perinatally exposed
More informationTunisian recommendations on ART : process and results
Second Arab Congress of Clinical Microbiology and Infectious Diseases May 24-26, 2012. Tunisian recommendations on ART : process and results M. BEN MAMOU UNAIDS Email: BenmamouM@unaids.org M. CHAKROUN
More informationPMTCT UPDATE. AWACC CONFERENCE DURBAN SEPT 2013 Dr HM Sebitloane Chief Specialist, Dept of O+G, NRMSM
PMTCT UPDATE AWACC CONFERENCE DURBAN SEPT 2013 Dr HM Sebitloane Chief Specialist, Dept of O+G, NRMSM Outline Background Risk of MTCT Historical ARV interventions SA PMTCT program Rationale for changes
More informationPREVENT TRANSMISSION OF HIV/AIDS PREGNANT WOMEN : LITERATUR REVIEW
PREVENT TRANSMISSION OF HIV/AIDS PREGNANT WOMEN : LITERATUR REVIEW *Nunung Nurhayati STIKep PPNI Jawa Barat, Bandung, West Java Indonesia Email: nunky_adzra@yahoo.com ABSTRACT Baby risk be infected HIV/AIDS
More informationThe NEW ARV Guidelines FAQs
The NEW ARV Guidelines FAQs Dr Madeleine Muller MBChB (Pret).MRCGP(Lon).Dip Hiv Man IYDSA Clinical Advisor Acknowledgments IYDSA for materials and support NDOH for slides CDC our funder HIV Clinician Society
More informationWESTERN CAPE ART GUIDELINES PRESENTATION 2013
WESTERN CAPE ART GUIDELINES PRESENTATION 2013 The WC guidelines are based on SA National ART guidelines dated 24th March 2013 Acknowledgement goes to members of the Adult and Paediatric HAST policy advisory
More informationThe Global Partnership for HIV-Free Survival (PHFS): Quality Improvement and Breastfeeding / ART compliance
The Global Partnership for HIV-Free Survival (PHFS): Quality Improvement and Breastfeeding / ART compliance TOPS Breastfeeding Seminar Washington, DC May 10, 2017 Amy F. Stern, URC Improvement Director
More informationDr Graham P Taylor Reader in Communicable Diseases
HIV in Pregnancy Joint RCOG/BHIVA Multidisciplinary Conference Dr Graham Taylor Imperial College London Friday 20 January 2012, Royal College of Obstetricians and Gynaecologist, London Prevention of post-partum
More informationPLANNING INTEGRATED HIV SERVICES AT THE HEALTH CENTRE
CHAPTER 2 PLANNING INTEGRATED HIV SERVICES AT THE HEALTH CENTRE 2.1 INTRODUCTION Achieving quality integrated HIV services at your health centre is dependant on good planning and management. This chapter
More informationPreliminary Outcomes of the PMTCT Option B+ programme in Thyolo District, Malawi
Preliminary Outcomes of the PMTCT Option B+ programme in Thyolo District, Malawi Spencer Nundwe 1, Oren Jalon 2, Reinaldo Ortuno 2, Carol Metcalf 3, Sarah Daho 1, Helen Bygrave 3, Michael Murowa 4, Kingsley
More informationPMTCT Counseling Support Flipchart
PMTCT Counseling Support Flipchart HOW TO USE THE COUNSELING CUE CARDS FLIPCHART The counseling cue cards flipchart was developed to support a range of providers (trained counselors, lay counselors, peer
More informationCare of the HIV-Exposed Infant
Care of the HIV-Exposed Infant Use of Flipchart To promote quality and consistency of counseling Why use the counseling flipchart? To improve HIV-exposed infant outcomes through high quality counseling.
More informationSCENARIO. Maternal Medicine- Intrapartum HIV LEARNING OBJECTIVES
SCENARIO Maternal Medicine- Intrapartum HIV LEARNING OBJECTIVES To be aware of the management of unbooked women with an unknown HIV status Be able to counsel women on potential new diagnosis of HIV To
More informationDr HM Sebitloane Chief Specialist (Outreach) Dept of O+G NRMSM
Dr HM Sebitloane Chief Specialist (Outreach) Dept of O+G NRMSM SA Background Population: 48m Annual number of deliveries:1,2m 97% of women attend the first ANC 71% of women attend 5 th ANC visit 97% of
More informationInfant feeding and HIV Policy, Evidence and Hospital Challenges
Infant feeding and HIV Policy, Evidence and Hospital Challenges Max Kroon MMH/SCAH MY BRIEF Overview of infant feeding within the PMTCT program including national policy, feeding choices & research evidence
More informationSafe Generations Harnessing Implementation Science to Assess the Impact of Option B+ in Swaziland
Safe Generations Harnessing Implementation Science to Assess the Impact of Option B+ in Swaziland Background and Rationale In 2015, the World Health Organization (WHO) endorsed universal treatment for
More informationInnovative Approaches for Eliminating Mother-to-Child Transmission of HIV. Mon Mari Mon Visa : Men as Change Agents in Côte d Ivoire
Innovative Approaches for Eliminating Mother-to-Child Transmission of HIV Mon Mari Mon Visa : Men as Change Agents in Côte d Ivoire 1 Optimizing HIV Treatment Access for Pregnant and Breastfeeding Women
More informationSouth African goals and national policy
Connecting the dots for EMTCT A Decade of PMTCT South Africa has been one of the counties in sub-saharan Africa to be hard hit by the HIV virus. Despite this, the country did not implement its PMTCT programme
More informationUsing new ARVs in pregnancy
Using new ARVs in pregnancy Dr Wendy Mphatswe SA HIV Clinician s Society Meeting 15 July 2017 Overview 1. HIV epidemic 2. HIV response (Fast Track) 3. Goal of therapy in pregnant and breastfeeding women
More informationIntegrating prevention & management of STI/HIV/AIDS into reproductive, maternal and newborn health services in China
Integrating prevention & management of STI/HIV/AIDS into reproductive, maternal and newborn health services in China China presentation Wang Linhong MD, Professor National Center of MCH, China CDC 1 HIV/AIDS
More informationElimination of New HIV Infections among Children by 2015 and Keeping their Mothers Alive:
Elimination of New HIV Infections among Children by 2015 and Keeping their Mothers Alive: Rationale for the call to action, progress to date and dealing with realities Rene Ekpini, MD, MPH Senior Adviser,
More informationKathryn Schnippel 1*, Constance Mongwenyana 1, Lawrence C Long 1 and Bruce A Larson 2
Schnippel et al. BMC Infectious Diseases (2015) 15:46 DOI 10.1186/s12879-015-0778-2 RESEARCH ARTICLE Open Access Delays, interruptions, and losses from prevention of mother-to-child transmission of HIV
More informationDiscontinuation of cart postpartum in a high prevalence district of South Africa in 2014
Claessens et al. Implementation Science 2014, 9:139 Implementation Science STUDY PROTOCOL Open Access Discontinuation of cart postpartum in a high prevalence district of South Africa in 2014 Lore Claessens
More informationObjectives. Outline. Section 1: Interaction between HIV and pregnancy. Effects of HIV on Pregnancy. Section 2: Mother-to-Child-Transmission (MTCT)
Objectives Prevention of Mother-to-Child Transmission (PMTCT) Teen Club Community Partners Training Programme By the end of the session participants will be able to: 1. Identify factors affecting the transmission
More informationNational Guidelines for the Prevention of Mother to Child Transmission of HIV
National Guidelines for the Prevention of Mother to Child Transmission of HIV Government of Lesotho September 2010 FOREWORD Mother to Child Transmission (MTCT) of HIV is by far the main source of HIV infection
More informationSESSION VI: Forecasting, estimating requirements for Procurement of HIV related supplies
ENSURING SECURE and RELIABLE SUPPLY and DISTRIBUTION SYSTEMS in DEVELOPING COUNTRIES, in the CONTEXT OF HIV/AIDS and PMTCT SESSION VI: Forecasting, estimating requirements for Procurement of HIV related
More informationHIV. Transmission modes. Transmission modes in children. Prevention of mother-to-child transmission of HIV. HIV identified in 1983
Prevention of mother-to-child transmission of HIV HIV identified in 1983 HIV AIDS syndrome described in 1981 Kaposi s sarcoma, Pneumocystis jiroveci pnemumonia and wasting often combined Retrospectively,
More informationNational PMTCT Program Annual Report 2012 Page 0
National PMTCT Program Annual Report 2012 Page 0 ACKNOWLEDGMENTS The Ministry of Health would like to extend its gratitude to all development partners who have provided financial and technical support
More informationMozambique Progress Report. High Level Global Partners Forum PMTCT, November 2007
Mozambique Progress Report High Level Global Partners Forum PMTCT, 26-27 November 2007 1. Background demographic and epidemiological data Mozambique s population is about 20 million (2007 census data).
More informationImpact of South Africa s PMTCT Programs on Perinatal HIV Transmission: Results of the 1st Year Implementing 2010 WHO Recommended Guidelines
Impact of South Africa s PMTCT Programs on Perinatal HIV Transmission: Results of the 1st Year Implementing 2010 WHO Recommended Guidelines Thu-Ha Dinh, MD., MS., US CDC/GAP Ameena Goga, MD., MS., MRC/HSRU,
More informationTRANSITION TO NEW ANTIRETROVIRALS IN HIV PROGRAMMES
POLICY BRIEF HIV TREATMENT TRANSITION TO NEW ANTIRETROVIRALS IN HIV PROGRAMMES JULY 2017 WHO This policy brief provides advice on a phased approach to transitioning to new WHO-recommended HIV treatment
More informationKingdom of Cambodia Nation Religion King
Kingdom of Cambodia Nation Religion King MINISRY OF HEALTH Joint NCHADS-NCMCH (*) Statement On the Implementation of the Prevention of Mother-to-Child Transmission of HIV/AIDS 1. Introduction The prevalence
More informationPaediatric ART: eligibility criteria and first line regimens. (revised) Dave le Roux 13 August 2016
Paediatric ART: eligibility criteria and first line regimens (revised) Dave le Roux 13 August 2016 Outline Eligibility criteria for starting ART Evolving evidence for earlier ART W Cape, National, WHO
More informationNo. individuals current on treatment (ART) - PEPFAR Indicator Reference Sheets
No. individuals current on treatment (ART) - PEPFAR Indicator Reference Sheets 2004-2009 Indicator Reference Sheet Number of individuals receiving antiretroviral therapy at the end of the reporting period,
More informationScaling up priority HIV/AIDS interventions in the health sector
TOWARDS UNIVERSAL ACCESS? Scaling up priority HIV/AIDS interventions in the health sector Yves Souteyrand, WHO October 2011 Towards universal access targets UN General Assembly High level Meeting June
More informationThe CQUIN Learning Network
The CQUIN Learning Network Adolescents Living with HIV: National Guidelines, Minimum Package, Challenges and Priorities Swaziland Ms Nobuhle Mthethwa MOH- SWAZILAND October 24-27, 2017 Johannesburg, South
More informationCHAI Cambodia: HIV Program Update NCHADS Annual Operational Comprehensive Planning Workshop Dec 3, 2012
CHAI Cambodia: HIV Program Update NCHADS Annual Operational Comprehensive Planning Workshop Dec 3, 2012 1 CHAI areas of collaboration with NCHADS 1. HIV Program Context: Background 1. emtct 2. Drug Access
More informationPositive health, dignity and prevention for women and their babies
FLIPCHART Positive health, dignity and prevention for women and their babies A treatment literacy guide for pregnant women and mothers living with HIV Module 1: Human rights in healthcare settings 1 Knowing
More informationCCC ARV Dosing Recommendations for HIV-exposed infants Updated
USERS NOTE: Please note this document does not provide guidance on overall decisionmaking regarding what medication(s) to use for HIV-exposed infants. This document is meant to facilitate ARV dosing for
More information1. Africa Centre for Health and Population Studies 2. London School of Hygiene and Tropical Medicine 3. University College London
A systematic review of the effects of interrupted antiretroviral interventions for prevention of mother-to-child transmission of HIV on maternal disease progression and survival Naidu KK 1, Mori R 2, Newell
More informationUse of a Multidisciplinary Care Model for Pregnant Women Living with HIV & Their Infants Sarah McBeth, MD MPH
Use of a Multidisciplinary Care Model for Pregnant Women Living with HIV & Their Infants Sarah McBeth, MD MPH University of Pittsburgh Medical Center Disclosures Presenter has no financial interests to
More informationManagement of HIV Infected Children and Adolescents: Public Sector Approach in Kenya
Management of HIV Infected Children and Adolescents: Public Sector Approach in Kenya KPA 2018 24-04-2018 Dr. Margaret Wainaina- Wafula Outline Introduction Evaluation of a child living with HIV. Standard
More informationDECLINE IN POSITIVITY RATES AMONG HIV-EXPOSED INFANTS WITH CHANGES IN PMTCT ARV REGIMENS IN NIGERIA: EVIDENCE FROM 7 YEARS OF FIELD IMPLEMENTATION
Abst#_O_01 DECLINE IN POSITIVITY RATES AMONG HIV-EXPOSED INFANTS WITH CHANGES IN PMTCT ARV REGIMENS IN NIGERIA: EVIDENCE FROM 7 YEARS OF FIELD IMPLEMENTATION Hadiza Khamofu, 1 Edward Oladele, 1 Uche Ralph-Opara,
More informationPrevention of Mother to Child Transmission of HIV: Our Experience in South India
pg 62-66 Original Article Prevention of Mother to Child Transmission of HIV: Our Experience in South India Karthekeyani Vijaya 1, Alexander Glory 2, Solomon Eileen 3, Rao Sarita 4, Rao P.S.S.Sunder 5 1
More informationImpact of Option B on mother-to-child HIV transmission in Rwanda: an interrupted time series analysis
Impact of Option B on mother-to-child HIV transmission in Rwanda: an interrupted time series analysis Monique Abimpaye, Hari S. Iyer, Michael Law, Catherine Kirk, Eric Remera, Placidie Mugwaneza, Neil
More informationA Descriptive Study of Outcomes of Interventions to Prevent Mother to Child Transmission of HIV in Lusaka, Zambia
ORIGINAL PAPER A Descriptive Study of Outcomes of Interventions to Prevent Mother to Child Transmission of HIV in Lusaka, Zambia Chibesa Shichitamba W, National Malaria Control Centre, Lusaka-Zambia ABSTRACT
More informationLinking HIV-exposed babies to HIV services through existing Health Programmes an effective strategy from Tamil Nadu, India
Linking HIV-exposed babies to HIV services through existing Health Programmes an effective strategy from Tamil Nadu, India Dr. Rachna William Tamil Nadu State AIDS Control Society Overview Introduction
More informationJOINT WHO/UNAIDS/UNICEF STATEMENT ON USE OF COTRIMOXAZOLE AS PROPHYLAXIS IN HIV EXPOSED AND HIV INFECTED CHILDREN
JOINT WHO/UNAIDS/UNICEF STATEMENT ON USE OF COTRIMOXAZOLE AS PROPHYLAXIS IN HIV EXPOSED AND HIV INFECTED CHILDREN WHO, UNAIDS and UNICEF, guided by recent evidence, have agreed to modify as an interim
More informationThe Cumulative Incidence of HIV Infection in HIVexposed Infants with a Birth Weight of 1500g Receiving Breast Milk and Daily Nevirapine
The Cumulative Incidence of HIV Infection in HIVexposed Infants with a Birth Weight of 1500g Receiving Breast Milk and Daily Nevirapine A retrospective, descriptive study conducted at Kalafong hospital,
More informationVirtual pediatric HIV elimination in Cambodia: Dr Mean Chhi Vun, Director, National Center for HIV/AIDS Dermatology and STD
Virtual pediatric HIV elimination in Cambodia: Dr Mean Chhi Vun, Director, National Center for HIV/AIDS Dermatology and STD The 3 rd Phnom Penh Symposium on HIV/AIDS, Prevention Care and Treatment 14 15
More informationCost-effectiveness of strategies to reduce mother-to-child HIV transmission in Mexico, a lowprevalence
Cost-effectiveness of strategies to reduce mother-to-child HIV transmission in Mexico, a lowprevalence setting Rely K, Bertozzi S M, Avila-Figueroa C, Guijarro M T Record Status This is a critical abstract
More informationThe Western Cape Consolidated Guidelines for HIV Treatment: Prevention of Mother- to- Child Transmission of HIV (PMTCT), Children, Adolescents and
The Western Cape Consolidated Guidelines for HIV Treatment: Prevention of Mother- to- Child Transmission of HIV (PMTCT), Children, Adolescents and Adults. 2015 (Amended Version) The Western Cape Consolidated
More informationDe la prévention à l élimination, le chemin parcouru en matière de transmission verticale. De la recherche aux recommandations OMS
De la prévention à l élimination, le chemin parcouru en matière de transmission verticale De la recherche aux recommandations OMS 16 novembre, 2011 Pr François DABIS Bordeaux 1985 1997 (1) 1985 1997 (1)
More informationHIV Treatment as Prevention (TasP)
HIV Treatment as Prevention (TasP) Last updated: April 3, 2019 Together, we can change the course of the HIV epidemic one woman at a time. #onewomanatatime #thewellproject What Is Treatment as Prevention?
More informationThe CQUIN Learning Network
The CQUIN Learning Network Innovations to reach the first 90 for children and adolescents: Lessons from Swaziland Dr. Lydia Mpango AIDSFree, Swaziland October 24-27, 2017 Johannesburg, South Africa Introduction
More informationUpdate on PMTCT. African Health Profession Regulatory Collaborative for Nurses and Midwives. Johannesburg, Republic of South Africa, June 18-22, 2012
PMTCT Update Update on PMTCT Margarett Davis, MD, MPH Chief, Maternal and Child Health Branch Division of Global HIV/AIDS Centers for Disease Control and Prevention (CDC) African Health Profession Regulatory
More informationThree years Option B+ in Malawi Success and challenges of a novel programme to prevent mother-to-child transmission of HIV
Three years Option B+ in Malawi Success and challenges of a novel programme to prevent mother-to-child transmission of HIV Olivia Keiser, PhD University of Bern, Switzerland okeiser@ispm.unibe.ch 1 Cascade
More informationOriginal Research Article. Bhagyalakshmi R. T. 1 *, T. P. Manjunath 1, C. R. Banapurmath 2, Mruthunjaya S. 2
International Journal of Community Medicine and Public Health Bhagyalakshmi RT et al. Int J Community Med Public Health. 2017 Apr;4(4):1332-1336 http://www.ijcmph.com pissn 2394-6032 eissn 2394-6040 Original
More informationPediatric HIV Update NORTHWEST AIDS EDUCATION AND TRAINING CENTER
NORTHWEST AIDS EDUCATION AND TRAINING CENTER Pediatric HIV Update Christian B. Ramers, MD, MPH Assistant Medical Director, Family Health Centers of San Diego HIV/HCV Distance Education Specialist - NWAETC,
More informationCommunity Client Tracing Through Community Health Workers in Côte d Ivoire
Innovative Approaches for Eliminating Mother-to-Child Transmission of HIV Community Client Tracing Through Community Health Workers in Côte d Ivoire 1 Optimizing HIV Treatment Access for Pregnant and Breastfeeding
More informationGoal of this chapter. 6.1 Introduction Good practices for linkage to care General care for people living with HIV 84
Clinical guidelines across THE CONTINuUM OF CARE: LINKING PEOPLE DIAGNOSEd WiTH hiv infection to hiv care and treatment 06 6.1 Introduction 84 6.2 Good practices for linkage to care 84 6.3 General care
More informationUPTAKE OF THE PREVENTION OF MOTHER- TO-CHILD-TRANSMISSION PROGRAMME AT A PRIMARY CARE LEVEL IN SEDIBENG DISTRICT
UPTAKE OF THE PREVENTION OF MOTHER- TO-CHILD-TRANSMISSION PROGRAMME AT A PRIMARY CARE LEVEL IN SEDIBENG DISTRICT A Research Report Submitted to the Faculty of Health Sciences, University of the Witwatersrand
More informationAdolescents Living with HIV
Adolescents Living with HIV Gary Reubenson Polokwane 22 August 2015 Conflicts of Interest No relevant conflicts of interest to declare Acknowledgements Karl Technau Lee Fairlie Gill Sorour HIV Clinicians
More informationtargets for HIV-positive children
Accessing antiretroviral therapy (ART) is a matter of life and death for HIV-infected children. Without ART, half of children born with HIV die by the age of two years, and 80 percent die by the age of
More informationHIV AND INFANT FEEDING
HIV AND INFANT FEEDING UPDATED WHO GUIDELINES, 2016 Nigel Rollins Maternal, Newborn, Child and Adolescent Health WHO guidelines http://www.who.int/hiv/en/ Setting national recommendations for infant feeding
More informationPRECONCEPTION COUNSELING
PRECONCEPTION COUNSELING A Counseling Guide for Healthcare Providers Preconception Care & Counseling 1 Introduction Pregnancy planning and preconception care are important in order to: 1. Ensure maternal
More informationseries kids QUESTION ANSWER What are antiretroviral drugs?
What are antiretroviral drugs? Antiretroviral drugs (ARVs) are given to people who have HIV, and a low CD4 count (CD4 cells are the cells in the body that fight illness and keep us healthy). ARVs help
More informationGlobal Plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive
Global Plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive DR. Nicholas Muraguri OGW, MD,MPH, MBA, PhD (c) Director, Global Plan Secretariat www.zero-hiv.org
More informationWHAT S NEW IN THE 2015 PERINATAL HIV GUIDELINES?
WHAT S NEW IN THE 2015 PERINATAL HIV GUIDELINES? Today s Webinar will be starting soon For the audio portion of this meeting: Dial 1-855-702-5382 Enter participant code 596-825-4701# Guidelines for online
More informationMATERNAL AND CHILD SURVIVAL MEMORANDUM OF CONCERN
MATERNAL AND CHILD SURVIVAL MEMORANDUM OF CONCERN We, the undersigned would like to raise our urgent concerns about the quality and coverage of prevention of mother-to-child transmission of HIV (PMTCT)
More informationPMTCT Max Kroon Mowbray Maternity Hospital Division of Neonatal Medicine School of Child and Adolescent Health University of Cape Town
PMTCT 2010 Max Kroon Mowbray Maternity Hospital Division of Neonatal Medicine School of Child and Adolescent Health University of Cape Town Prevention of Mother-To-Child Transmission of HIV or Prevention
More informationINTRODUCTION AND GUIDING PRINCIPLES
CHAPTER 1 INTRODUCTION AND GUIDING PRINCIPLES The Operations Manual is intended for use in countries with high HIV prevalence and provides operational guidance on delivering HIV services at health centres.
More informationPAEDIATRIC PROVIDER INITIATED TESTING AND COUNSELLING
PAEDIATRIC PROVIDER INITIATED TESTING AND COUNSELLING This checklist is offered as an aid to support supervision and quality assurance for paediatric PITC services. Through observation, interviews and
More informationUsing new ARVs in pregnancy
Using new ARVs in pregnancy Dr Kerry Uebel Slides courtesy of Linda-Gail Bekker With thanks to CN Mnyani SA HIV Clinician s Society Meeting 5 August 2017 We have effective drugs. There is no reason why
More informationStrengthening the Integration of PMTCT within MNCH Services
Strengthening the Integration of PMTCT within MNCH Services ACCESS APPROACH While not planned as a major focus of the ACCESS Program, the prevention of mother-to-child transmission of HIV/AIDS (PMTCT)
More informationUganda. HIV Country Pro le: Maternal mortality per live births (2015) Health expenditure, total (% of GDP) (2015)
WHO/CDS/HIV/18.50 Demographic and socioeconomic data Uganda HIV Country Pro le: 2017 42.9 million Total population (2017) 1 820 US$ GNI per capita, PPP (2017) 343 Maternal mortality per 100 000 live births
More information